Visitors Now:
Total Visits:
Total Stories:
Profile image
Story Views

Now:
Last Hour:
Last 24 Hours:
Total:

Glaucoma Treatment Market by Global Volume Overview Analysis & Forecast

Friday, November 11, 2016 8:53
% of readers think this story is Fact. Add your two cents.

(Before It's News)

The report titled “Global Glaucoma Treatment Market: Trends and Opportunities (2015 Edition)” analyzes the potential opportunities, challenges, demand drivers and significant trends representing the Glaucoma treatment market. The report elucidates facts on the glaucoma treatment market as supplemented by the latest available statistics. It also profiles and analyzes the leading four companies operating in this industry with latest data and a brief overview of their business and financial performance along with a brief discussion of their future business strategies. The report gives valuable insight into technology used in glaucoma treatment market, its demand in various geographies. In the report, we also try to study the growth pattern in the prescriptions and revenue earned by the glaucoma treatment companies and the latest trends concerning glaucoma treatment market. Most importantly, we have analyzed the current market size and project future market size of the overall glaucoma treatment market for the years to come.

 

For more information about this report: http://www.reportsweb.com/global-glaucoma-treatment-market-trends-and-opportunities-2015-edition

 

Company Coverage
- Biolite Israeli
- Pfizer Inc.
- Merck & Co. Inc.
- Alcon ( A division of Novartis)

Products Covered
- Prostaglandin
- Combination Market
- Carbonic Anhydrase Inhibitor
- Beta Blocker
- Alpha Agonist & Cholinergic
- Surgical Devices

 

Company Profiles:

Global Glaucoma Market
1. Biolight Israeli 
1.1 Business Overview 
1.2 Financial Overview 
1.3 Business Strategies 

2. Pfizer Inc. 
2.1 Business Overview 
3.2 Financial Overview 
3.3 Business Strategies 

3. Merck & Co. Inc. 
3.1 Business Overview 
3.2 Financial Overview 
3.4 Business Strategies 

4. Alcon (A division of Novartis) 
4.1 Business Overview 
4.2 Financial Overview 
4.3 Business Strategies 

 

Request Sample Copy at http://www.reportsweb.com/inquiry&RW000182019/sample

 

Executive Summary

The global Glaucoma market has been growing rapidly since the past several years mainly due to innovation such as introduction of IOPtiMa, OTP-TX, anti-VEGF therapy, photodynamic therapy (PDT) laser photocoagulation, Rhopressa, latanoprost and Vesneo. Among the several varieties of drugs and surgeries available in the market, the demand for drugs such as Prostaglandins which includes Trabatan, Lumbigan are the highest due to its high efficiency in treating glaucoma. Vesneo has shown a superior intraocular pressure reduction effect on beta-blocker timolol, the most widely used comparator in registration trials for glaucoma, in two phase 3 studies.

Globally, the major factors contributing to the growth of Glaucoma treatment market is the higher number of glaucoma patients from the U.S, Europe and Japan. Novel therapies for glaucoma are constantly being investigated by research and development teams of various pharmaceutical companies, at different stages. It can be predicted that novel therapies that work in conjunction with current drugs, such as Prostaglandins, will likely be increasingly common in the near future.

Growth of the Glaucoma treatment market could also be attributed to North America where the number of patients suffering from glaucoma is the highest among the rest of the U.S and also from emerging markets such as France and Singapore driven by rapid increase of old age population. Moreover, the Asian market is expected to become a huge potential market for glaucoma surgery devices in the foreseeable future, as it is expected to grow at comparatively the fastest among all other regions. It is estimated that by 2020, 11 million individuals will have vision loss due to glaucoma.

Glaucoma market is seen as a diversifying risk to other lines of ophthalmic treatment business and is attracting more and more revenue. Glaucoma treatment companies are launching new technologies and adopting new strategies in the industry and making significant investments.

 

Inquire Before Buying at http://www.reportsweb.com/inquiry&RW000182019/buying

 

Contact Us:

Call: +1-646-491-9876
Email: sales@reportsweb.com

Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories

Register

Newsletter

Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.